Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 27998223

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2016 Dec 20
First author
von Stackelberg A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      von Stackelberg A
      type
      Author
    2. name
      Locatelli F
      type
      Author
    3. name
      Zugmaier G
      type
      Author
    4. name
      Handgretinger R
      type
      Author
    5. name
      Trippett TM
      type
      Author
    6. name
      Rizzari C
      type
      Author
    7. name
      Bader P
      type
      Author
    8. name
      O'Brien MM
      type
      Author
    9. name
      Brethon B
      type
      Author
    10. name
      Bhojwani D
      type
      Author
    11. name
      Schlegel PG
      type
      Author
    12. name
      Borkhardt A
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      von Stackelberg A
      type
      Author
    2. name
      Locatelli F
      type
      Author
    3. name
      Zugmaier G
      type
      Author
    4. name
      Handgretinger R
      type
      Author
    5. name
      Trippett TM
      type
      Author
    6. name
      Rizzari C
      type
      Author
    7. name
      Bader P
      type
      Author
    8. name
      O'Brien MM
      type
      Author
    9. name
      Brethon B
      type
      Author
    10. name
      Bhojwani D
      type
      Author
    11. name
      Schlegel PG
      type
      Author
    12. name
      Borkhardt A
      type
      Author
    bibliography ids
    1. nci-bib-f08278aea14d75bce84b9814
    book metadata
    content sha256
    9506612d7d3e03e6fc1e5ee42621d8359677133e0f25a545a371b8d31f4bffec
    document type
    citation
    dois
    1. 10.1200/JCO.2016.67.3301
    electronic publication date
    display
    2016 Oct 31
    precision
    day
    year
    2016
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:27998223
    immutable id
    pubmed:27998223@9506612d7d3e03e6fc1e5ee42621d8359677133e0f25a545a371b8d31f4bffec
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    36
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    4381-4389
    volume
    34
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      27998223
      provenance
      batch id
      7a1288ac8bb5f9826304
      provider
      NCBI PubMed ESummary
      record sha256
      18a6f602e5eee1c10905246a264bc641aeb3ccce84cca954908e0bc6a7db0a67
      response sha256
      0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
      retrieved at
      2026-09-09T23:47:23.138359+00:00
      publication date
      display
      2016 Dec 20
      precision
      day
      year
      2016
      publication types
      1. Clinical Trial, Phase I
      2. Clinical Trial, Phase II
      3. Comparative Study
      4. Journal Article
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/27998223/
      title
      Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.

      Preserved source evidence · Not medical advice